VASOCON-A
LOE ApproachingNDAOPHTHALMICSOLUTION/DROPS
Approved
Apr 1990
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 18h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
VASOCON-A is an ophthalmic solution approved in 1990 for use as eye drops. The mechanism of action and specific indications are not publicly detailed in available data, but the product targets ocular conditions requiring topical administration. As a small-molecule ophthalmic agent, it represents a mature, established therapeutic option in the eye care market.
LOE Approaching
Product is in late-stage maturity with approaching loss of exclusivity; commercial teams are likely focused on defending market share and managing decline rather than growth initiatives.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on VASOCON-A offers limited career growth opportunity, as the product is in defensive, late-lifecycle management rather than growth or launch phase. Roles available are primarily focused on protecting market share, managing costs, and preparing for generic competition rather than innovation or expansion.
Brand ManagerField Sales Representative
Worked on VASOCON-A at Novartis? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.